Feb 12, 2024
1:12
For every 12 shares held, investors received 1.
The split itself did not change the total investment value.
Assembly Biosciences, Inc. (GETTEX:V7B) operates in the Pharmaceuticals: major industry.
Assembly Biosciences, Inc. company overviewAssembly Biosciences, Inc.'s most recent stock split was on February 12, 2024. It was a 1-for-12 reverse split, so shareholders received 1 share for every 12 they held.
Assembly Biosciences, Inc. (GETTEX:V7B) has split its stock 2 times: a 1-for-5 reverse split on July 14, 2014 and a 1-for-12 reverse split on February 12, 2024.
Assembly Biosciences, Inc. has split its stock 2 times. This history records 2 reverse splits between July 14, 2014 and February 12, 2024.
A reverse stock split combines several shares into one and raises the price per share by the same factor, so the total value of a holding does not change. In Assembly Biosciences, Inc.'s 1-for-12 reverse split on February 12, 2024, every 12 shares became one share. Companies often use reverse splits to lift a low share price, for example to keep meeting an exchange's minimum price requirement.
Assembly Biosciences, Inc. has not announced a new split in our records. Its most recent split was on February 12, 2024, 2 years ago. Companies announce splits in advance, and any new GETTEX:V7B split will appear on this page.